Interruption of coronary flow during cardiac surgical procedures provides a bloodless flaccid heart and allows precise and rapid correction of complex cardiac defects. However, myocardial damage occurs in direct proportion to the duration of the ischemia. As the induction of cardioplegia simultaneous with the initiation of cardiac ischemia helps to preserve cardiac energy reserves and thus myocardial integrity, the identification of a consistently reliable cardioplegic technique is desirable. Isolated perfused working rat hearts were made ischemic for one hour by aortic cross-clamping and were compared with hearts rendered cardioplegic at the onset of ischemia by the intracoronary administration of 5 ml of a hypothermic solution: 1) Krebs-Henseleit buffer, 2) Ringer's lactate, 3) tetrodotoxin, 4) potassium chloride, or 5) potassium citrate. Cardiac output, heart rate, aortic pressure and coronary flow were determined pre and post-ischemia. When compared to time-matched controls and hearts arrested with potassium or tetrodotoxin, the ischemia and ischemia-Ringer's lactate groups showed significant post cross-clamp depression of all measured parameters. Intracoronary Ringer's lactate, although often used as an adjunct to ischemic arrest, was not of significant value. In contrast, hearts arrested with tetrodotoxin, potassium chloride or potassium citrate showed no significant post-ischemic functional or histologic deficit. Perfusion with hypothermic Krebs-Henseleit buffer protected the myocardium better than did Ringer's lactate but less well than the tetrodotoxin or isotonic high potassium solutions. The induction of hypothermic metabolic arrest of the heart by briefly perfusing the coronary arteries via the aortic root with isotonic buffered solutions results in markedly improved myocardial tolerance to one hour of ischemia and avoids the problems of low cardiac output and ventricular irritability previously reported with hypertonic potassium citrate arrest.
THE RELATIVE EASE with which complex operations can be accomplished when the heart is both flaccid and unperfused has led many surgeons to induce cardiac arrest by cross-clamping the ascending aorta.' Although this method of arresting the heart facilitates the performance of cardiac surgical procedures and shortens the duration of cardiopulmonary bypass, the heart is permitted to contract until energy reserves are depleted2 and myocardial damage may result. Because of the sporadic occurrence of irreversible myocardial damage following ischemic arrest and because techniques of coronary perfusion, perfusion with induced ventricular fibrillation and cold irrigation of the pericardial sac are inconvenient and also on occasion unreliable, there is considerable interest in the development of a safe and consistent means of preserving myocardial integrity during an interval of ischemic arrest. The immediate induction of cardio-plegia at the onset of ischemia is of considerable benefit in this regard because myocardial energy reserves are spared from the rapid depletion which otherwise follows discontinuation of coronary perfusion.2 '3 Despite the fact that nearly 20 years have passed since Melrose reported on potassium citrate-induced cardioplegia,4 the best means of inhibiting myocardial deterioration during induced ischemic arrest remains in question. In this paper we report on our studies of reversible hypothermic and metabolic cardioplegic agents undertaken in an attempt to develop a technique permitting prolonged intervals of ischemic cardiac arrest without functional or histological sequelae.
Methods
Rats of the Sprague-Dawley strain weighing 150-200 gm were fasted overnight before experimental use. Heparin sodium (5 mg/rat) and sodium pentobarbital (30 mg/rat) were injected intraperitoneally and when adequate anesthesia was achieved, the thoracic cavity was entered and the beating heart was removed by means of a scissors cut along its posterior-superior aspect. Upon removal from the chest, the heart was immediately dropped into a beaker containing chilled (10°C) saline.
The heart was removed from the saline bath and the aorta was slipped onto the grooved cannula of the working heart apparatus ( fig. 1) Figure 1 Isolated working heart apparatus. overflow trap situated 78 cm above the heart where it was returned to the system except once every 15 minutes when it was collected in a graduated cylinder for determination of cardiac output. The height of this column provided the afterload necessary to maintain coronary flow which was also determined every 15 minutes by collecting the perfusate drip-off from the heart in a graduated cylinder. Between flow measurements all perfusate returned to the system for oxygenation and recirculation by a peristaltic pump. A closed bubble trap containing a 4 ml air bubble was situated halfway between the aortic valve and the top of the 78 cm column. This simulated the resiliency of the normal ascending aorta and resulted in a fairly normal pulsatile pressure tracing including a dicrotic notch ( fig. 2 ). Although diastolic pressures are a little low with this technique, coronary flow is excellent and a smaller air bubble reduces the compliance of the system to the point where ventricular damage ensues. Aortic pressure and heart rate were continuously monitored with a recorder and pressure transducer connected into the aortic line.
Control hearts were perfused for 21/2 hours but the satisfactory nature of the system has been established by the continued function of a previous set of 12 hearts for up to eight hours without significant deterioration of cardiac function. 6 The experimental hearts were subjected to ischemic arrest by clamping both the atrial inflow and aortic outflow lines and immediately received one of the following treat- Administration of the arrest solutions was accomplished through a self-sealing injection cap positioned just above the aortic cannula. During perfusion all hearts were maintained at 37°C within a water-jacketed heating chamber. At the time of aortic cross-clamping, the arrested hearts were moved a few centimeters above the heating chamber so that the ischemic arrest hearts drifted down towards room temperature during the 60 minute arrest while the hypothermic perfusion arrest hearts drifted up towards room temperature, both situations closely simulating the clinical setting. The control and each of the six experimental categories contained seven hearts.
After the designated ischemic interval of one hour, all experimental hearts were perfused retrograde through the aortic root with oxygenated buffer for 15 minutes and the buffer was discarded to eliminate all traces of the arresting agent from the system. The working heart preparation was then re-established for 45 minutes following which the hearts were removed from the apparatus and either dried and weighed or fixed in 10% neutral buffered formalin, sectioned at 5g and stained with hematoxylin and eosin. Ischemic damage was graded on a scale of [1] [2] [3] [4] 
Results
Following the induction of ischemia, untreated hearts continued to contract for up to five minutes. In contrast, each of the cardioplegic solutions injected into the coronary circulation effected an almost immediate halt of all mechanical activity. No difficulties were encountered with ventricular irritability in any arrested heart when coronary perfusion was reinstituted.
F-

Hemodynamic Results
The effects on cardiac output, coronary flow, heart rate, and aortic pressure of uninterrupted control perfusion, ischemia, and ischemia modified by hypothermic arrest solutions are shown in tables [1] [2] [3] [4] Circulation, Volume 52, December 1975 was clearly superior to the I or I-RL groups, it did not perform as well in the 60 minute period following the ischemia as did the I-TTX, I-KCI or I-KCIT groups. Significant I-KHB reductions were noted when compared with I-KCIT with regard to aortic pressure late in the post-ischemic period and with regard to cardiac output at one point (135 min) in the post-ischemic period. While heart rate of the I-KCIT group was less than time-matched controls at two of the post-ischemic determinations this was, in part, related to the slow pre-ischemic rate in the citrate group. No rate differences were seen when the I-KCIT, I-KCI and I-TTX groups were compared.
Histopathological Results
After one hour of normothermic ischemic arrest and one hour of recovery, hematoxylin and eosin stained sections of the left ventricular myocardium were characterized by focal necrosis, myofibrillar degeneration, loss of cross striations and pyknotic nuclei -all slides grade 3 or 4, over 50 or over 75% of cells damaged. In hearts arrested with any of the hypothermic cardioplegic solutions, hemotoxylin and eosin sections revealed only mild edema and occasional myofibrillar fragmentation -all slides grade 1, less than 25% of cells damaged. There was no evidence of loss of cross striations. These changes were indistinguishable from those observed in control hearts perfused for 21/2 hours.
Discussion
An hour of ischemia was studied because this duration is adequate for the performance of most cardiac operations and is uniformly injurious to the myocardium.7 Shorter periods of ischemia do not consistently irreversibly damage either the in situ human heart' or the isolated working rat heart.2 Despite statements supporting aortic cross-clamping to induce cardiac arrest by Wesolowski,8 Nunn,9 Cooley," and others and despite repeated attempts to estimate a safe ischemic period' [11] [12] [13] there exist wide individual variations in myocardial tolerance to ischemia with the result that normothermic ischemic cardiac arrest is an unpredictable technique. In contrast, the present study shows that induced cardiac arrest with tetrodotoxin, potassium chloride or potassium citrate preserved normal cardiac functional and histological integrity after one hour of ischemia. The high potassium solutions depolarized the myocardial cells.
Tetrodotoxin, on the other hand, inhibited depolarization of neuronal and cardiac conductive tissue by a selective blockade of sodium ion inflow.'4 '5 While tetrodotoxin and the high potassium solutions exerted their cardioplegic effects through different mechanisms, the end result was similar, preservation of myocardial high energy phosphates2 3 and maintenance of myocardial integrity. Tetrodotoxin may prove useful for protection of donor hearts while preparations are being made for cardiac transplantation, but systemic toxicity precludes its use during cardiopulmonary bypass.
The poor results obtained with intracoronary Ringer's lactate administration are significant. UrschelP' first used this solution for cardiac perfusion hypothermia and reported good results but subsequent studies have yielded conflicting conclusions. '7' '8 In previous studies in the dog on cardiopulmonary bypass, we compared 60 minutes of normothermic ischemic arrest of the myocardium, with cold Ringer's lactate perfusion of the coronary arteries followed by 60 minutes of ischemic arrest. Significant functional7 and structural7' 19 preservation were demonstrable with the selective myocardial hypothermia, but pre-arrest status was never maintained and late arrhythmias were common. The results of the present study demonstrate only minimal benefit from intracoronary Ringer's lactate administration during induced ischemic arrest. The lack of acute functional and histological changes in tissues which go on to develop chronic arrhythmias and fibrosis after ischemia are well established, making the greater sensitivity of the isolated working rat heart preparation an asset for the screening of myocardial preservation methods. 6 The 28 mEq/L of lactate and low pH of the Ringer's may contribute to the acidosis of ischemic arrest and thus offset the protective effect of the hypothermia. Nonlactate, metabolically inactive intracoronary hypothermic solutions were of more value in reducing ischemic myocardial damage as evidenced by the results obtained with the I-KHB group but the protective effect was less pronounced than that observed when a metabolic inhibitor and hypothermia were combined.
Melrose4 first used potassium to induce cardiac arrest in 1955 and promising results were reported by Lam et al. 20 and Effler et al. 21 However, difficulties with ventricular fibrillation and ineffective cardiac action were reported by a number of investigators9 11, 22 and potassium arrest was subsequently abandoned. Recent studies have indicated that hypertonicity23 and citrate24 rather than potassium may have been the injurious factors with Melrose arrest. The present study indicates that there is no detrimental effect on myocardial function when a buffered isotonic solution of either potassium chloride or potassium citrate is injected into the coronaries in a concentration that produces immediate arrest. No difficulties were encountered with arrhythmias in the post-ischemic period following arrest with either potassium solution. FurCirculation, Volume 52, December 1975 ther preclinical studies to carefully assess the possible role of buffered potassium solution-induced ischemic cardiac arrest are indicated.
